ArticleCureus2025

A Stable Switch From Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/FTC/TAF) to Dolutegravir/Lamivudine (DTG/3TC) in the Absence of Historical Resistance Records: Results From the Switch to Dovato in Patients Suppressed on Biktarvy (SOUND) Cohort.

Jihad Slim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.